These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10109993)

  • 21. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
    Skitek M
    Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
    [No Abstract]   [Full Text] [Related]  

  • 23. [Screening for colorectal tumors using fecal occult blood studies].
    Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
    Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
    Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
    Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test].
    Launoy G
    Pathol Biol (Paris); 2009 Sep; 57(6):488-92. PubMed ID: 18834677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
    Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
    Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.
    Castiglione G; Grazzini G; Ciatto S
    Br J Cancer; 1992 Jun; 65(6):942-4. PubMed ID: 1616868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green-coloured results on guaiac-based faecal occult blood testing.
    Anthony T
    Ann Clin Biochem; 2005 May; 42(Pt 3):234; author reply 235. PubMed ID: 15949163
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunochemical fecal occult blood tests for colorectal cancer screening.
    Allison JE
    Am J Med; 2004 Apr; 116(7):498; author reply 498-9. PubMed ID: 15047043
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunochemical testing for colorectal cancer.
    Scholefield JH
    Lancet Oncol; 2006 Feb; 7(2):101-3. PubMed ID: 16455472
    [No Abstract]   [Full Text] [Related]  

  • 31. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FIT: a valuable but underutilized screening test for colorectal cancer-it's time for a change.
    Allison JE
    Am J Gastroenterol; 2010 Sep; 105(9):2026-8. PubMed ID: 20818351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
    Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
    J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
    Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
    Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of combining a immunological fecal occult blood test (latex method) with a chemical test (guaiac method)].
    Hamajima E; Asai T; Okumura S; Yamaguchi H; Katou T; Yamamoto Y; Kinoshita O
    Gan No Rinsho; 1990 Jan; 36(1):71-4. PubMed ID: 2299793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal occult blood testing when colonoscopy capacity is limited.
    Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
    J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of a colorectal cancer screening program based on a guaiac test: a population-based study.
    Giai J; Exbrayat C; Boussat B; Poncet F; Bureau du Colombier P; Colonna M; Seigneurin A
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):106-11. PubMed ID: 23896367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.